Bellerophon Therapeutics, Inc.
BLPH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $9 | $29 | $52 | $24 |
| - Cash | $7 | $25 | $48 | $10 |
| + Debt | $0 | $1 | $2 | $2 |
| Enterprise Value | $2 | $6 | $6 | $16 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$22 | -$19 | -$27 | -$15 |
| % Margin | – | – | – | – |
| Net Income | -$20 | -$18 | -$25 | -$13 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.08 | -1.87 | -3.17 | -2.95 |
| % Growth | -11.2% | 41% | -7.5% | – |
| Operating Cash Flow | -$18 | -$23 | -$20 | -$13 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$18 | -$23 | -$20 | -$13 |